NCT06721611View on ClinicalTrials.gov

A Comprehensive Optical Blood Pressure Assessment Tool to Identify Cases of Unscreened Hypertension Across an Active Population in the U.S.

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

January 16, 2025

Primary Completion Date

July 16, 2025

Study Completion Date

August 31, 2025

Conditions
Hypertension
Interventions
DEVICE

Optical Blood Pressure Monitoring Device (Aktiia G1)

"Non-hypertensive Nucor employees that accept to wear an optical blood pressure monitoring device (Aktiia 24/7 device) to screen for and identify potential undiagnosed hypertension.~100 participants. Each participant will wear the device continuously for 28 days."

Trial Locations (1)

28211

Nucor, Charlotte

Sponsors

Lead Sponsor

Nucor
All Listed Sponsors
lead

Nucor

INDUSTRY

NCT06721611 - A Comprehensive Optical Blood Pressure Assessment Tool to Identify Cases of Unscreened Hypertension Across an Active Population in the U.S. | Biotech Hunter | Biotech Hunter